Last updated on December 28, 2021
Supriya Lifescience IPO description – The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with focus on research and development. As of 31 October 2021, it had niche product offerings of 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic. The company has consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India, contributing to 45-50% and 60-65%, respectively, of the API exports from India, between Fiscal 2017 and 2021. It was among the largest exporters of Salbutamol Sulphate in India contributing to 31% of the API exports from India in FY 2021 in volume terms.
Its pharmaceutical business is organized into domestic and export sales. From 1 April 2020 until 31 October 2021, its products were exported to 86 countries to 1,296 customers including 346 distributors. Its customers include global pharma companies such as Syntec Do Brasil LTDA, American International Chemical Inc and AT Planejamento E Desenbolvimento De Negocios Ltda, with whom we have business relationship for over nine years, and Suan Farma Inc, Acme Generics LLP, Akum Drugs Ltd and Mankind Pharma Ltd with whom it has business relationship for over four years.
Supriya Lifescience’s business operations are supported by a manufacturing facility located in Parshuram Lote, Maharashtra, which is approximately 250 km from Mumbai, Maharashtra. The manufacturing facility is spread across 23,806 sq. mts, having reactor capacity of 547 KL/ day and seven cleanrooms. In addition, the company has acquired a plot of land, admeasuring 12,551 sq.mt, near the present manufacturing facility, wherein it intends to expand its manufacturing infrastructure.
Promoters of Supriya Lifescience Limited – Satish Waman Wagh
- Supriya Lifescience IPO Details
- Supriya Lifescience’s Financial Performance
- Supriya Lifescience IPO News
- Supriya Lifescience Valuations & Margins
- Supriya Lifescience IPO GMP Daily Trend
- Supriya Lifescience IPO Subscription – Live Updates
- Supriya Lifescience IPO Reviews – Subscribe or Avoid?
- Supriya Lifescience Offer Registrar
- Supriya Lifescience Contact Details
- Supriya Lifescience IPO Allotment Status
- Supriya Lifescience IPO Timetable
- Supriya Lifescience IPO FAQs
Supriya Lifescience IPO Details
|Subscription Dates||16 – 20 December 2021|
|Price Band||INR265 – 274 per share|
|Fresh issue||INR200 crore|
|Offer For Sale||INR500 crore|
|Total IPO size||INR700 crore|
|Minimum bid (lot size)||54 shares|
|Face Value||INR 2 per share|
|Listing On||NSE, BSE|
Supriya Lifescience’s Financial Performance
Supriya Lifescience IPO News
- Supriya Lifescience IPO Allotment: Check Status in 4 Easy Ways
- Supriya Lifescience IPO Review: Better then listed peers
- Supriya Lifescience RHP
- Supriya Lifescience DRHP
Supriya Lifescience Valuations & Margins
|PE ratio||–||–||15.66 – 16.19|
Supriya Lifescience IPO GMP Daily Trend
|Date||Supriya Lifescience IPO GMP||Kostak||Subject to Sauda|
|27 Dec 2021||INR150||INR200||INR4,000|
|25 Dec 2021||INR130||INR200||INR4,000|
|24 Dec 2021||INR150||INR200||INR4,000|
|23 Dec 2021||INR120||INR200||INR3,500|
|22 Dec 2021||INR100||INR150||INR3,000|
|21 Dec 2021||INR130||INR150||INR3,500|
|20 Dec 2021||INR150||INR150||INR3,500|
|18 Dec 2021||INR250||INR200||INR4,000|
|17 Dec 2021||INR220||INR200||INR3,800|
|16 Dec 2021||INR250||INR250||INR3,800|
|15 Dec 2021||INR250||INR300||INR4,000|
|14 Dec 2021||INR250||–||–|
Supriya Lifescience IPO Subscription – Live Updates
|Category||Shares Offered||Day 1||Day 2||Day 3|
Supriya Lifescience IPO Reviews – Subscribe or Avoid?
Angel One – Subscribe
Anand Rathi – Subscribe for long term
Antique Stock Broking –
Arihant Capital –
Ashika Research – Subscribe
Asit C Mehta –
BP Wealth – Subscribe
Canara Bank Securities – Subscribe
Choice Broking – Subscribe
Elite Wealth – Subscribe
GEPL Capital –
Hem Securities – Subscribe
ICICIdirect – Unrated
KR Choksey –
Marwadi Financial Services – Subscribe
Motilal Oswal – Subscribe
Nirmal Bang – Subscribe
Religare Broking –
Samco Securities – Subscribe
SMC Global – 2.5/5
Ventura Securities – Subscribe
Supriya Lifescience Offer Registrar
Link Intime India Private Limited
C-101, 1st Floor,
247 Park Lal Bahadur Shastri Marg,
Vikhroli (West) Mumbai – 400 083
Phone: +91 22 4918 6200
Fax: +91 22 4918 6195
Email: [email protected]
Supriya Lifescience Contact Details
Supriya Lifescience Limited
207/208, Udyog Bhavan,
Sonawala Road, Goregaon – East,
Mumbai – 400063, Maharashtra
Phone: +91 22-40332727
Email: [email protected]
Supriya Lifescience IPO Allotment Status
Supriya Lifescience IPO allotment is now available on Link Intime’s website. Click on this link to get allotment status.
Supriya Lifescience IPO Timetable
|IPO Opening Date||16 December 2021|
|IPO Closing Date||20 December 2021|
|Finalisation of Basis of Allotment||23 December 2021|
|Initiation of refunds||24 December 2021|
|Transfer of shares to demat accounts||27 December 2021|
|Listing Date||28 December 2021|
|Opening Price on NSE||INR421 per share (up 53.65% from IPO price)|
|Closing Price on NSE||INR389.7 per share (up 42.23% from IPO price)|
Supriya Lifescience IPO FAQs
How many shares in Supriya Lifescience IPO are reserved for HNIs and retail investors?
The investors’ portion for QIB – 75%, NII – 15%, and Retail – 10%.
How to apply in Supriya Lifescience Public Offer?
The best way to apply in Supriya Lifescience IPO is through Internet banking ASBA (know all about ASBA here). You can also apply online through your stock broker using UPI. If you prefer to make paper applications, fill up an offline IPO form and deposit the same to your broker.
What is Supriya Lifescience IPO GMP today?
Supriya Lifescience IPO GMP today is INR150 per share.
What is Supriya Lifescience IPO kostak rate today?
Supriya Lifescience IPO kostak rate today is INR200 per application.
What is Supriya Lifescience Subject to Sauda rate today?
Supriya Lifescience Subject to Sauda rate today is INR4,000 per application.